Surgery Partners To Go Private In $5.7 Billion Deal With Bon Secours Mercy Health Affiliate

Shareholders outside Bain Capital would get $23.50 a share in cash, while Bain rolls its roughly 39% stake into the buyer.

Share
Surgery Partners To Go Private In $5.7 Billion Deal With Bon Secours Mercy Health Affiliate

HealthSpan Partners, an affiliate of the nonprofit hospital system Bon Secours Mercy Health, agreed to buy Surgery Partners, an operator of outpatient surgery centers, in an all-cash deal at an enterprise value of about $5.7 billion, the companies said Monday. Nasdaq had halted the stock at 8:16 a.m. ET pending news.

$23.50 a share, with Bain rolling over

Shareholders other than affiliates of Bain Capital Private Equity would receive $23.50 in cash per share, according to the joint press release. SGRY closed at $15.75 on Friday.

Bain, the largest shareholder with about 39% of the outstanding shares, will swap its stake for equity in the acquiring entity and stay on as a partner. It has also agreed to vote all its shares in favor.

A special committee of independent directors led the negotiations, and the board approved the deal on its unanimous recommendation. John M. Starcher, Jr., president and CEO of Bon Secours Mercy Health, said the combination would help "strengthen access to more affordable care."

A national surgery network

Surgery Partners, based in Brentwood, Tennessee, runs ambulatory surgery centers, surgical hospitals and physician practices. It has more than 200 locations in 30 states and about 5,000 affiliated physicians, the companies said.

After closing, its name, brand and headquarters are expected to stay in place. It is expected to remain a secular organization and will not be treated as a Catholic ministry entity. Its stock will leave Nasdaq and the company will be privately held.

Vote, fee and timetable

The buyers expect to close in the first quarter of 2027. Approval requires a majority of outstanding shares and a majority of votes cast by disinterested holders. Regulatory approvals are also needed. Debt financing commitments are in place, and the deal has no financing condition.

Surgery Partners would owe a $108,986,842 termination fee in specified circumstances, including if it ends the agreement to accept a superior proposal. The agreement's outside date is July 23, 2027, and the company will file a proxy statement for the vote.

Bain's roughly 39% stake is already committed in favor, so the vote hinges on the remaining holders and on regulators.

Sources